Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Gürkan Kertiş"'
Autor:
Figen Barut, Aykut Barut, Gürkan Kertiş, Sibel Bektaş, Banu Doğan Gün, Burak Bahadır, Gamze Yurdakan, Şükrü Oğuz Özdamar
Publikováno v:
Gynecology Obstetrics & Reproductive Medicine, Vol 14, Iss 1 (2008)
OBJECTIVE: There are numerous types of ovarian tumors, both benign and malignant. The aim of this study was to evaluate the epidemiology of ovarian tumors in Zonguldak and surrounding cities, retrospectively. STUDY DESIGN: Between May 2001 and March
Externí odkaz:
https://doaj.org/article/34b2d4e15860444a8d366bfe37b3549e
Autor:
Mustafa Comert, Bulent Hamdi Ucan, Ali Ugur Emre, Burak Bahadir, Gürkan Kertiş, Oktay Irkorucu, Canan Demirtas, Hatice Pasaoglu, Handan Ankarali, Oge Tascilar, Guldeniz Karadeniz Cakmak, Kemal Karakaya, Ebru Ofluoglu
Publikováno v:
International Journal of Surgery. 7(1):39-43
Introduction: Sildenafil may lead an improvement in anastomotic healing of ischemic left colon anastomosis. Methods: Thirty-six male Wistar albino rats were randomized into four experimental groups (n = 9 in each group). In group 1, a well-perfused l
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3a2c8cecc2bf3a18bd049ca07788601f
Autor:
Oktay Irkorucu, Hatice Pasaoglu, Oge Tascilar, Kemal Karakaya, Mustafa Comert, Serefden Acikgoz, Canan Demirtas, G. Karadeniz Cakmak, Bulent Hamdi Ucan, Ali Ugur Emre, Handan Ankarali, Burak Bahadir, Gürkan Kertiş
Publikováno v:
Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract. 13(9)
Annual Congress on Turkish National Surgery -- MAY, 2008 -- Antalya, TURKEY
WOS: 000268575000024
PubMed: 19578821
Simvastatin is a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor commonly known as a cholesterol-lowering drug
WOS: 000268575000024
PubMed: 19578821
Simvastatin is a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor commonly known as a cholesterol-lowering drug
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9bb8d35618011319e41b9f87314186fa
https://pubmed.ncbi.nlm.nih.gov/19578821
https://pubmed.ncbi.nlm.nih.gov/19578821
Amaç: Bu çalışmada, bilgisayar destekli görüntü analiz sistemi kullanılarak prostatik adenokarsinom hücre nükleuslarının boyut ve şekil özellikleri değerlendirilmiş, sonuçlar olguların Gleason skorları ile karşılaştırılmışt
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::09d540ff5a002747142c6f7d8e4c8bee
https://hdl.handle.net/20.500.12628/8216
https://hdl.handle.net/20.500.12628/8216
Autor:
Ali Ugur Emre, Mustafa Comert, Handan Ankarali, Kemal Karakaya, Oktay Irkorucu, Guldeniz Karadeniz Cakmak, Gürkan Kertiş, Burak Bahadir, Hakan Balbaloglu, Bulent Hamdi Ucan, Ishak Ozel Tekin, Oge Tascilar, Serefden Acikgoz
WOS: 000251840200007
PubMed: 18069756
AIM: To investigate the effect of exogenous erythropoietin (EPO) administration on acute lung injury (ALI) in an experimental model of sodium taurodeoxycholate-induced acute necrotizing pancreatitis (AN
PubMed: 18069756
AIM: To investigate the effect of exogenous erythropoietin (EPO) administration on acute lung injury (ALI) in an experimental model of sodium taurodeoxycholate-induced acute necrotizing pancreatitis (AN
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8ed74f5f25409cbc1ef1da60542fe139
https://hdl.handle.net/20.500.12628/3184
https://hdl.handle.net/20.500.12628/3184
Autor:
Burak Bahadir, Gamze Numanoglu, Gamze Mocan Kuzey, Banu Dogan Gun, Şükrü Oğuz Özdamar, Gürkan Kertiş, Hüseyin Engin, Yucel Ustundag
Publikováno v:
Journal of Clinical Oncology. 24:16041-16041
16041 Background: 600 patients diagnosed as having cancer between years 2000–2005 at Zonguldak Karaelmas University were evaluated. Methods: All information pertaining to patient characteristics were retrieved from files of the Pathology and Medica
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::44aca23921b90c9cfda3620b55cf6964
https://doi.org/10.1200/jco.2006.24.18_suppl.16041
https://doi.org/10.1200/jco.2006.24.18_suppl.16041
Autor:
Guldeniz Karadeniz Cakmak, Ebru Ugurbas, Mustafa Comert, Gürkan Kertiş, Muzaffer Onder Oner, Mesut Gül
Publikováno v:
International Journal of Surgery. (1):59-63
Background and aim: The liver shows remarkable regeneration ability after damage or resection. The main stimulant for hepatic regeneration is resection. Erythropoietin (EPO), which was initially used for anemia therapy, is today known as a general ti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::482f851412569f4bc52b1acc7497bf63